Home Supplements How We Rate Blog
Iron

Iron

Research reviewed: Up until 03/2026

Iron is a dietary supplement with 4 published peer-reviewed studies involving 1,399 participants, researched for Fatigue & Iron Deficiency Without Anaemia, Blood Donors — Iron Recovery & Deficiency Prevention, General Health.

4
Studies
1,399
Participants
2012–2025
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Fatigue & Iron Deficiency Without Anaemia

Moderate
1 study 0 of 1 positive 198 participants

Blood Donors — Iron Recovery & Deficiency Prevention

Strong
2 studies 2 of 2 positive 1,045 participants

General Health

Moderate
1 study 1 of 1 positive 156 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

4/4
Randomised
2/4
Double-Blind
2/4
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2012)
198
Study 1 (2025)
830
Study 2 (2015)
215
Study 1 (2012)
156

Research Timeline

When the studies were published

2
2012
1
2015
1
2025

All Studies

Detailed breakdown of each trial. Click to expand.

Fatigue & Iron Deficiency Without Anaemia

1

To determine the effects of oral iron supplementation on fatigue in non-anaemic menstruating women with low ferritin (iron stores) who present with unexplained tiredness

2012 198 participants 12 weeks 80 mg elemental iron/day (ferrous sulphate) or placebo
Human Study RCT Positive

Study Type

Multicentre, parallel, randomised controlled, observer-blinded trial

Purpose

To determine the effects of oral iron supplementation on fatigue in non-anaemic menstruating women with low ferritin (iron stores) who present with unexplained tiredness

Dose

80 mg elemental iron/day (ferrous sulphate) or placebo

Participants

198 women aged 18–53 years

Duration

12 weeks

Results

Researchers observed that fatigue scores decreased significantly more in the iron group compared to placebo. The CPPS score (a questionnaire that measures how tired someone feels in daily life; higher scores mean more fatigue) significantly dropped by 47.7% with iron versus 28.8% with placebo—a difference of −18.9%. Haemoglobin (the part of blood that carries oxygen) also significantly increased by +0.32 g/dL, showing better oxygen delivery in the body. Ferritin (a marker of iron stores; low levels mean low reserves) increased by +11.4 µg/L, and sTfR (a marker that rises when the body lacks usable iron; lower is better) decreased by −0.54 mg/L, indicating improved iron availability in the body. However, there were no significant changes in quality of life, depression, or anxiety scores.

Read full study

Blood Donors — Iron Recovery & Deficiency Prevention

1

To determine the optimal dose and frequency of iron supplementation for whole-blood donors with low ferritin, comparing 30 mg vs 60 mg and daily vs alternate-day dosing, and assessing whether iron supplementation can replace the need for extended donation intervals

2025 830 participants 56 days Ferrous bisglycinate capsules: 0 mg (placebo), 30 mg, or 60 ...
Human Study RCT Double-Blind Placebo Positive

Study Type

Double-blind, randomised, placebo-controlled trial

Purpose

To determine the optimal dose and frequency of iron supplementation for whole-blood donors with low ferritin, comparing 30 mg vs 60 mg and daily vs alternate-day dosing, and assessing whether iron supplementation can replace the need for extended donation intervals

Dose

Ferrous bisglycinate capsules: 0 mg (placebo), 30 mg, or 60 mg of elemental iron, administered either daily or on alternate days for 56 days; six study groups in total

Participants

830 regular whole-blood donors (464 female, 366 male; average age ~44 years)

Duration

56 days

Results

Researchers observed that all four iron supplementation groups significantly reduced the risk of iron deficiency (ferritin < 15 µg/L, where ferritin is a measure of iron stored in the body; low levels mean low iron reserves) compared to placebo after 56 days. The odds ratios ranged from 0.60 to 0.65, meaning those taking iron were about 35–40% less likely to become iron deficient. The most effective was daily 60 mg iron, which reduced the risk of low ferritin (15–30 µg/L) by 48%. Low haemoglobin (the oxygen-carrying part of blood; low levels can cause fatigue and weakness) was also significantly less common in all iron groupsImportantly, there were no increases in stomach-related side effects, and participants were just as willing to return, showing the supplement was well tolerated even at higher doses.

Read full study
2

To determine the effect of low-dose oral iron supplementation on the speed of haemoglobin and ferritin recovery in blood donors following a standard unit donation

2015 215 participants 168 days (24 weeks) One tablet of ferrous gluconate (37.5 mg elemental iron) dai...
Human Study RCT Positive

Study Type

Randomised, non-blinded clinical trial

Purpose

To determine the effect of low-dose oral iron supplementation on the speed of haemoglobin and ferritin recovery in blood donors following a standard unit donation

Dose

One tablet of ferrous gluconate (37.5 mg elemental iron) daily or no iron supplement following a single whole blood donation

Participants

215 blood donors aged 18–79 years

Duration

168 days (24 weeks)

Results

Researchers observed that in people with low iron stores, haemoglobin (the part of blood that carries oxygen) recovery was significantly higher in those taking iron, reaching 106.0% of their original levels, meaning they recovered to above their pre-donation levels. In contrast, those without iron supplementation dropped to 98.1%, meaning they actually fell below normal and became mildly anaemic (low red blood cells). Ferritin (a measure of iron stored in the body) also recovered much faster, taking a median of 76 days with iron versus more than 168 days without supplementation. Without iron, 67% of donors did not recover their iron stores within the study period

Read full study

General Health

1

To assess the effect of iron supplementation on fatigue in nonanemic menstruating women with low iron stores

2012 156 participants 12 weeks 80 mg elemental iron daily (as ferrous sulfate)
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomized, double-blind, placebo-controlled trial

Purpose

To assess the effect of iron supplementation on fatigue in nonanemic menstruating women with low iron stores

Dose

80 mg elemental iron daily (as ferrous sulfate)

Participants

156 nonanemic menstruating women aged 18-53 years with ferritin levels <50 μg/L

Duration

12 weeks

Results

Iron supplementation significantly reduced fatigue by ~50% from baseline, with 19% greater improvement compared to placebo. Effect was dose-dependent

How They Measured It

Fatigue Severity Scale, serum ferritin, hemoglobin levels

Read full study

Frequently Asked Questions

Common questions about Iron research

What does the research say about Iron?

There are currently 4 peer-reviewed studies on Iron (Iron), involving 1,399 total participants. Research covers Fatigue & Iron Deficiency Without Anaemia, Blood Donors — Iron Recovery & Deficiency Prevention. The overall evidence strength is rated as Strong.

How strong is the evidence for Iron?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (4 human studies), and reported outcomes.

What health goals has Iron been studied for?

Iron has been researched for: Fatigue & Iron Deficiency Without Anaemia, Blood Donors — Iron Recovery & Deficiency Prevention. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Iron based on human trials?

Yes, 4 out of 4 studies are human trials. Human trials carry more weight in our evidence scoring system.